Spinal cord modulation for inhibiting pain via short pulse width waveforms, and associated systems and methods
Short pulse width spinal cord modulation for inhibiting pain with reduced side effects and associated systems and methods are disclosed. In particular embodiments, modulation signal has pulse widths in the range of from about 10 microseconds to about 50 microseconds may be applied to the patient's spinal cord region to address chronic pain without using paresthesia or tingling to mask or cover the patient's sensation of pain. In other embodiments, modulation in accordance with similar parameters can be applied to other spinal or peripheral locations to address other indications.
1. A spinal cord stimulation system for reducing or eliminating pain in a patient, the system comprising:
an implantable signal generator having a computer-readable medium with instructions to generate and transmit a non-paresthesia-producing therapy signal, wherein at least a portion of the therapy signal is at a frequency of from 1,000 Hz to 1,500 Hz, with a pulse width in a pulse width range from 10 microseconds to 50 microseconds, and a current amplitude in a current amplitude range from 0.5 to 20 mA; and
a signal delivery device electrically coupleable to the implantable signal generator and designed to be implanted in the patient's epidural space to deliver the therapy signal to the dorsal column of the patient's spinal cord.
2. The system of claim 1 , wherein the implantable signal generator generates the therapy signal at a duty cycle.
3. The system of claim 2 , wherein the duty cycle is 50-100%.
4. The system of claim 2 , wherein the frequency is applied throughout the length of an on period in the duty cycle.
5. The system of claim 2 , wherein the frequency is applied during a portion of an on period in the duty cycle.
6. The system of claim 1 , wherein the frequency is from 500 Hz to 1,200 Hz.
7. The system of claim 1 , wherein the frequency is from 1,200 Hz to 1,500 Hz.
8. The system of claim 1 , wherein the amplitude is from 2 to 18 mA.
9. The system of claim 1 , wherein the amplitude is from 5 to 15 mA.
10. The system of claim 1 , wherein the amplitude is from 7 to 10 mA.
11. The system of claim 1 , wherein the amplitude is from 0.5 to 7 mA.
12. The system of claim 1 , wherein the therapy signal is delivered at a current amplitude of about 2.5 mA.
13. The system of claim 1 , wherein the pulsewidth is from 20 to 40 microseconds.
14. The system of claim 1 , wherein the pulsewidth is from 25 to 35 microseconds.
15. The system of claim 1 , wherein the pulsewidth is from 30 to 35 microseconds.
16. The system of claim 1 , wherein at least a portion of the therapy signal is a square-wave signal.
17. The system of claim 1 , wherein the signal delivery device is a percutaneous lead.
18. The system of claim 1 , wherein the signal delivery device is a paddle lead.
19. A spinal cord stimulation system for reducing or eliminating pain in a patient, the system comprising:
an implantable signal generator that, in operation, generates a non-paresthesia-producing therapy signal, wherein at least a portion of the therapy signal is at a frequency of from 1,000 Hz to 1,500 Hz, with a pulse width in a pulse width range from 10 microseconds to 50 microseconds, and a current amplitude in a current amplitude range from 0.5 mA to 20 mA; and
a signal delivery device electrically coupled to the implantable signal generator to deliver the therapy signal to the dorsal column of the patient's spinal cord.
20. The system of claim 19 , wherein the implantable signal generator generates the therapy signal at a duty cycle.
21. The system of claim 20 , wherein the duty cycle is 100%.
22. The system of claim 20 , wherein the duty cycle is 50-100%.
23. The system of claim 20 , wherein the frequency is applied throughout the length of an on period in the duty cycle.
24. The system of claim 20 , wherein the frequency is applied during a portion of an on period in the duty cycle.
25. The system of claim 19 , wherein the therapy signal is delivered at a current amplitude of 2.5 mA.
26. The system of claim 19 , wherein at least a portion of the therapy signal is a square-wave signal.
27. The system of claim 19 , wherein the signal delivery device is a percutaneous lead.
28. The system of claim 19 , wherein the signal delivery device is a paddle lead.
29. The system of claim 19 , wherein the signal delivery device is an elongated lead having one or more electrodes.
30. The system of claim 19 , wherein the signal delivery device is an elongated lead having a bipole arrangement of electrodes.
31. The system of claim 19 , wherein the frequency is from 500 Hz to 1,200 Hz.